Silence Therapeutics issues updated corporate presentation on June 23, 2026

Silence Therapeutics plc

Updated corporate presentation posted to investor section of company website.
Presentation contains business updates but no specific financial or clinical data disclosed.
Filing under Item 7.01; presentation furnished as Exhibit 99.1.
No material new information provided in the 8-K itself.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.